https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-02-15 / Int. J. Cancer 2009 Feb;124(4):877-88
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-02-15 / Int. J. Cancer 2009 Feb;124(4):877-882009-02-15 00:00:002019-02-15 08:38:02Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):25-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):25-82009-01-01 00:00:002019-02-15 08:38:02Recent advances in cancer immunotherapy with an emphasis on vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-17 / J. Leukoc. Biol. 2008 Oct;84(4):981-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-17 / J. Leukoc. Biol. 2008 Oct;84(4):981-72008-06-17 00:00:002019-02-15 08:38:03The essential role of the in situ immune reaction in human colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-03 / Ann. Surg. Oncol. 2008 Aug;15(8):2310-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-03 / Ann. Surg. Oncol. 2008 Aug;15(8):2310-72008-06-03 00:00:002021-11-15 17:04:28Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-17 / Cancer Immunol. Immunother. 2009 Jan;58(1):61-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-17 / Cancer Immunol. Immunother. 2009 Jan;58(1):61-92008-05-17 00:00:002021-11-15 17:04:52Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-28 / World J. Gastroenterol. 2008 Jan;14(4):532-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-28 / World J. Gastroenterol. 2008 Jan;14(4):532-402008-01-28 00:00:002019-02-15 08:38:06An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-03 / Immunol. Lett. 2008 Feb;116(1):24-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-03 / Immunol. Lett. 2008 Feb;116(1):24-322007-12-03 00:00:002019-02-15 08:38:06Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Int J Hyperthermia 2007 Nov;23(7):591-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Int J Hyperthermia 2007 Nov;23(7):591-82007-11-01 00:00:002019-02-15 08:39:22Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Nov;23(11):1046-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Nov;23(11):1046-92007-11-01 00:00:002019-02-15 08:38:09[The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-01 / Cancer 2007 Oct;110(7):1469-77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-01 / Cancer 2007 Oct;110(7):1469-772007-10-01 00:00:002019-02-15 08:38:10Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines